AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
RIFAXIMIN 550 Mg ;
18 registrations across 1 African market— 18 active
Markets with RIFAXIMIN 550 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Refixana 550 mg Film Coated Tablets | 🇪🇬Egypt | P and C Labs - Pellets and CR Products | active | — |
| Gutrifa 550mg Film Coated Tablets | 🇪🇬Egypt | Advanced Biopharmaceutical Company-Egypt | active | — |
| Oxorifax 550 mg Film Coated Tablets | 🇪🇬Egypt | International advanced pharmaceutical industries (INAD pharma) | active | — |
| Refixana 550 mg Film Coated Tablets | 🇪🇬Egypt | P and C Labs - Pellets and CR Products | active | — |
| Traveria 550mg Film Coated Tablets | 🇪🇬Egypt | Western Pharmaceuticals Industries | active | — |
| Traviguard 550mg Film Coated Tablets | 🇪🇬Egypt | Trend Pharm for Pharmaceuticals | active | — |
| Gutrifa 550mg Film Coated Tablets | 🇪🇬Egypt | Advanced Biopharmaceutical Company-Egypt | active | — |
| Oxorifax 550 mg Film Coated Tablets | 🇪🇬Egypt | International advanced pharmaceutical industries (INAD pharma) | active | — |
| Rifaximin 550mg Film Coated Tablets | 🇪🇬Egypt | Therapeutica Pharmaceuticals | active | — |
| Dufaximin 550 mg Film Coated Tablets | 🇪🇬Egypt | AUG Pharma | active | — |
| Trencedia 550 Film Coated Tablets | 🇪🇬Egypt | Marcyrl pharmaceutical industries - MPI | active | — |
| Rifaxerose 550 mg Film Coated Tablets | 🇪🇬Egypt | AVERROES PHARMA for pharmaceutical industries | active | — |
| Traviguard 550mg Film Coated Tablets | 🇪🇬Egypt | Trend Pharm for Pharmaceuticals | active | — |
| Rifaximin 550mg Film Coated Tablets | 🇪🇬Egypt | Therapeutica Pharmaceuticals | active | — |
| Biofaximin 550 mg Film Coated Tablets | 🇪🇬Egypt | SAJA Pharmaceuticals Egypt - SAJA | active | — |
| Dufaximin 550 mg Film Coated Tablets | 🇪🇬Egypt | AUG Pharma | active | — |
| Trencedia 550 Film Coated Tablets | 🇪🇬Egypt | Marcyrl pharmaceutical industries - MPI | active | — |
| Biofaximin 550 mg Film Coated Tablets | 🇪🇬Egypt | SAJA Pharmaceuticals Egypt - SAJA | active | — |
RIFAXIMIN 550 Mg ; in Africa — Regulatory Overview
RIFAXIMIN 550 Mg ; is registered across 1 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 18 registrations, 18 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.